ASXL1 and Buschke-Ollendorff syndrome: To our knowledge, there are three human and disease-specific data sets in which transcriptomic, and in the case of BOS, protein data, confirm the abnormal activation of Wnt signaling markers associated with ASXL1 variant [28, 33, 95].